Document is current
Any future updates will be listed below
-
Authors
Simone, Simona https://orcid.org/0000-0002-2569-3558
Pesce, Francesco https://orcid.org/0000-0002-2882-4226
Fontò, Giulia https://orcid.org/0000-0002-3559-5791
Pronzo, Virginia https://orcid.org/0000-0002-3955-6319
Pontrelli, Paola https://orcid.org/0000-0002-7654-8318
Conserva, Francesca https://orcid.org/0000-0003-2863-864X
Schirinzi, Annalisa https://orcid.org/0000-0001-9826-7907
Casanova, Annalisa https://orcid.org/0000-0003-0829-0420
Gallo, Pasquale https://orcid.org/0000-0001-8914-2600
Rossini, Michele https://orcid.org/0000-0002-5801-4136
Lucarelli, Giuseppe https://orcid.org/0000-0001-7807-1229
Spilotros, Marco https://orcid.org/0000-0003-1237-3018
Rendina, Maria https://orcid.org/0000-0003-0077-6629
Stallone, Giovanni https://orcid.org/0000-0002-2862-9017
Di Serio, Francesca https://orcid.org/0000-0001-6089-1165
Di Leo, Alfredo https://orcid.org/0000-0003-2026-1200
Tafuri, Silvio https://orcid.org/0000-0003-4194-0210
Ditonno, Pasquale https://orcid.org/0000-0001-7718-7676
Gesualdo, Loreto https://orcid.org/0000-0002-4861-0911
-
Funding
Funding for this research was provided by:
Università degli Studi di Bari Aldo Moro
- License Information
-
More Information
Article History
Received: 6 September 2022
Accepted: 15 April 2023
First Online: 17 July 2023
Declarations
:
: LG received fees from FRESENIUS, ESTOR, WERFEN, ASTELLAS, ASTRAZENECA, TRAVERE, SANDOZ, SANOFI, BAXTER, MUNDIPHARMA, ESTOR, PHARMADOC, RETROPHIN, TRAVERE, ASTRAZENECA, GSK, NOVARTIS, CHINOOK, ROCHE, MEDTRONIC for activities of invited speaker and consultant.
: The Local Ethics Committees approved the study protocol (study n°6845, prot. n°0050551).
: The study including human participants has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.
: Written informed consent was obtained before enrolment.
